Cefamandole and Cefoxitin

Publisher Website
Google Scholar
Abstract
Cefamandole and cefoxitin, introduced only 7 yr ago, are now the most commonly prescribed parenteral antibiotics in the USA. These drugs are similar to the 1st generation cephalosporins in toxicity, but their in vitro spectrum of activity is greater. Their serum half-lives are longer than those of cephalothin and cephapirin but shorter than that of cefazolin. Although cefamandole has been recommended in empiric therapy for patients with community-acquired pneumonia and as a prophylactic agent for patients having various surgical procedures, other regimens are less expensive and just as effective. Cefamandole should not be used to treat intra-abdominal, enterobacter, or ampicillin-resistant Haemophilus influenzae infections. Cefoxitin is effective in the treatment and prevention of mixed aerobic-anaerobic skin and soft-tissue, intra-abdominal, gynecologic and penicillinase-producing, spectinomycin-resistant Neisseria gonorrhoeae infections. Cefoxitin represents a greater advance than cefamandole in our continuing search for safe and more effective antimicrobial agents.

This publication has 127 references indexed in Scilit: